Name | Number of supported studies | Average coverage | |
---|---|---|---|
mesothelial cell | 4 studies | 49% ± 23% | |
type I pneumocyte | 4 studies | 28% ± 7% | |
adipocyte | 3 studies | 29% ± 6% | |
podocyte | 3 studies | 79% ± 28% |
Insufficient scRNA-seq data for expression of PTPRQ at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 1207.82 | 646 / 653 | 9% | 0.22 | 57 / 605 |
lung | 96% | 469.96 | 555 / 578 | 7% | 0.23 | 78 / 1155 |
bladder | 86% | 1146.52 | 18 / 21 | 14% | 0.82 | 73 / 504 |
kidney | 92% | 1735.83 | 82 / 89 | 1% | 0.02 | 7 / 901 |
adipose | 83% | 611.84 | 997 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 79% | 279.67 | 1057 / 1335 | 0% | 0 | 0 / 0 |
prostate | 67% | 199.20 | 165 / 245 | 5% | 0.36 | 27 / 502 |
breast | 55% | 129.22 | 251 / 459 | 6% | 0.40 | 68 / 1118 |
esophagus | 46% | 207.52 | 664 / 1445 | 3% | 0.12 | 5 / 183 |
heart | 47% | 157.86 | 402 / 861 | 0% | 0 | 0 / 0 |
skin | 41% | 402.68 | 746 / 1809 | 1% | 0.01 | 3 / 472 |
ovary | 26% | 50.43 | 47 / 180 | 13% | 0.46 | 56 / 430 |
uterus | 18% | 41.55 | 31 / 170 | 7% | 0.20 | 32 / 459 |
pancreas | 20% | 25.31 | 67 / 328 | 4% | 0.20 | 7 / 178 |
brain | 15% | 29.05 | 391 / 2642 | 1% | 0.03 | 7 / 705 |
muscle | 13% | 14.86 | 103 / 803 | 0% | 0 | 0 / 0 |
stomach | 9% | 14.16 | 34 / 359 | 1% | 0.15 | 4 / 286 |
intestine | 9% | 12.88 | 90 / 966 | 0% | 0.01 | 2 / 527 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.11 | 2 / 45 |
adrenal gland | 0% | 0.38 | 1 / 258 | 3% | 0.10 | 8 / 230 |
liver | 1% | 1.08 | 3 / 226 | 2% | 0.08 | 8 / 406 |
peripheral blood | 0% | 0.23 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990264 | Biological process | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity |
GO_0045598 | Biological process | regulation of fat cell differentiation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0120044 | Cellular component | stereocilium base |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRQ |
Protein name | Protein tyrosine phosphatase receptor type Q protein-tyrosine-phosphatase (EC 3.1.3.48) Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48) |
Synonyms | |
Description | FUNCTION: Phosphatidylinositol phosphatase required for auditory function. May act by regulating the level of phosphatidylinositol 4,5-bisphosphate (PIP2) level in the basal region of hair bundles. Can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. Has low tyrosine-protein phosphatase activity; however, the relevance of such activity in vivo is unclear. Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regulates the phosphorylation state of AKT1 by suppressing the phosphatidylinositol 3,4,5-trisphosphate (PIP3) level in MSCs and preadipocyte cells. . |
Accessions | A0A087X0B9 F8VW52 F8VXI2 F8W122 ENST00000551042.5 H0YIJ5 ENST00000547881.1 Q9UMZ3 ENST00000644991.3 ENST00000616559.4 ENST00000551573.5 ENST00000547376.5 A0A087WZU1 |